For research & informational purposes only.  Nothing on this site is medical advice or a recommendation to use any compound.

GHK-Cu

Copper tripeptide-1 (glycyl-L-histidyl-L-lysine bound to copper)
Status: Widely used in cosmetics (topical) Evidence: Best human data here, for skin Route: Topical (cosmetic) Injectable: Research only

What it is

GHK-Cu is a small three-amino-acid peptide (glycine-histidine-lysine) naturally bound to a copper ion. It was first isolated from human blood plasma in 1973. Like several compounds here, its natural levels decline with age. It is the most established compound in this library for skin, with decades of cosmetic research behind it and routine use in commercial skincare.

How it works

GHK-Cu is a signalling molecule. In skin it stimulates production of collagen, elastin and glycosaminoglycans (the structural and water-holding components of the dermis), supports wound healing, and influences the activity of enzymes that remodel tissue. Copper itself is a cofactor for several skin-repair enzymes, which is thought to enhance its activity. Some research suggests it can influence gene expression toward a "younger" pattern.

What the evidence shows

The strongest human evidence is topical and cosmetic. Multiple controlled studies have measured real improvements in skin.

~28%
avg collagen density increase, 3 months topical (21-woman trial)
70%
of volunteers showed increased collagen in one comparison trial
20–30%
reported skin-firmness gains over 12 weeks in some studies
  • A controlled trial in women found GHK-Cu eye cream outperformed both placebo and vitamin K cream for reducing lines and improving skin density and thickness.
  • In a comparison against vitamin C and retinoic acid, topical GHK-Cu produced collagen increases in a majority of volunteers.
  • Strong supporting evidence comes from animal and cell wound-healing models, where it consistently boosts collagen synthesis, angiogenesis and wound closure.
An honest caveat Not every study is glowing. One trial on laser-resurfaced skin found no statistically significant independent wrinkle improvement from GHK-Cu, though a perceptible improvement was noted. Cosmetic concentrations and formulations vary widely, which affects results.
Topical skin (human)
Reasonable
Wound healing (animal)
Strong
Injectable use evidence
Minimal
Cosmetic track record
Long

Topical vs injectable

This distinction matters. GHK-Cu's good reputation rests almost entirely on topical cosmetic use, where it is well established and generally regarded as safe at typical concentrations (around 0.2–2%). The injectable use promoted in some peptide circles is a different proposition with far less human evidence and falls into research-only territory.

Where it stands

As a topical cosmetic ingredient, GHK-Cu is legitimate, widely used and supported by human data, the clear standout in this library for evidence quality in its intended use. Claims about injected GHK-Cu, or systemic anti-aging effects beyond the skin, are far less supported.

Research & informational purposes only This page summarises published research. It is educational and not a recommendation to use GHK-Cu in any particular form.

References

  1. Pickart L, Margolina A. Regenerative and Protective Actions of Copper Peptides. Cosmetics, 2018. MDPI
  2. Effects of Topical Copper Tripeptide Complex on CO2 Laser-Resurfaced Skin. Archives of Facial Plastic Surgery. Article
  3. Epigenetic mechanisms activated by GHK-Cu increase skin collagen density (clinical trial). EurekAlert
  4. Copper peptide GHK-Cu — wound-healing evidence overview. Reference summary